To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

4,840.00a day ago
5,036.00a day ago
arrow

LOWER/UPPER CIRCUITS

4,528.50
5,534.50
arrow
Alkem Laboratories Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 3.7%, in the last year to ₹13,458.26 Cr. Its sector's average revenue growth for the last fiscal year was 10.77%.
noteAnnual Net Profit,rose 20.59% in the last year to ₹2,165.48 Cr. Its sector's average net profit growth for the last fiscal year was 38.71%.
notePrice to Earning Ratio,is 27.05, lower than its sector PE ratio of 43.86.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 23.06%
Net profit growth 5Y CAGR : 18.55%

STOCK RETURNS

info
Versus Nifty 50
1 w
+2.02%
vs
-0.83%
1 mth
+3.25%
vs
-2.59%
3 mth
-0.32%
vs
+2.14%
6 mth
+0.72%
vs
+5.73%
1 yr
-3.95%
vs
-0.39%
3 yr
+58.12%
vs
+44.86%
5 yr
+91.56%
vs
+124.46%
Alkem Laboratories Limited is among India’s leading global pharmaceutical companies. The company develops, manufactures and markets high-quality pharmaceutical products across all major therapeutic segments. The Company is a leading player in the acute therapeutic segment and a fast-growing player in the chronic therapeutic segment. India operations are underpinned by a robust sales and distribution network and extensive brand building and marketing efforts. The Company’s International business, built on a strong platform of a large and growing product pipeline, is a core part of its growth. These products are distributed through the Company’s own sales and commercial infrastructure.
personal

Grow your wealth with more research recommendations

+91